Cancelled. Replaced by DHA-PI 6025.21, Guidance for Gender-Affirming Health Care of Transgender and Gender-Diverse Active and Reserve Component Service Members
This Defense Health Agency-Administrative Instruction establishes the Defense Health Agency’s oversight procedures for all DHA conducted or supported research with humans, human data, or human specimens.
This Defense Health Agency Policy Memorandum addresses risk-based stratification of the obstetric population, based upon the level of maternal and neonatal care offered at every military medical treatment facility.
Establishes DHA’s procedures to identify and delineate responsibilities associated with the reimbursement of patient travel.
Identification #: 7000.01
Type: DHA-PI
Page 845 of 855, showing items 12661 - 12675
You are leaving Health.mil
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
